Journal
NEUROPHARMACOLOGY
Volume 55, Issue 7, Pages 1095-1104Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2008.07.047
Keywords
Cannabinoid; Anandamide; 2-Arachidonoylglycerol; Delta(9)-tetrahydrocannabinol; Membrane microdomain
Categories
Funding
- National Institutes of Health [R21 DA018112]
Ask authors/readers for more resources
Anandamide (AEA) and 2-arachiclonyl glycerol (2-AG), endogenous ligands for the CB1 and CB2 cannabinoid receptors, are referred to as endocannabinoids because they mimic the actions of delta(9)-tetrahydrocannabinol (Delta(9)-THC), a plant-derived cannabinoid. The processes by which AEA and 2-AG are biosynthesized, released, taken up by cells and hydrolyzed have been of much interest as potential therapeutic targets. In this review we will discuss the progress that has been made to characterize the primary pathways for AEA and 2-AG formation and breakdown as well as the role that specialized membrane microdomains known as lipid rafts play in these processes. Furthermore we will review the recent advances made to track and detect AEA in biological matrices. (C) 2008 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available